Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Regular ✕Baroda BNP Paribas ESG Best-in-Class Strategy Fund · Regular ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseInvescoBaroda BNP
NAV₹10.7400₹10.7822
NAV date20 Nov 202620 Nov 2026
History2 months9 months
Expense ratio3.8%2.7%
StarsNot ratedNot rated
Growth Score——

Returns

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
1 month+19.60%+9.56%
3 months—+1.27%
6 months—+5.81%
YTD——
1 year——
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+7.29%+7.64%

Risk

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−11.50%−10.40%
Days to recover1443
Below its high+0.00%+0.00%

Against benchmark

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
Best 1-year——
Middle 1-year——
Worst 1-year——
1-year periods with a loss——
Middle 3-year——
Positive months——
Best day+3.52%+2.40%
Worst day−2.74%−1.90%
Worst 5% day−1.46%−1.11%
Positive days46.8%53.7%
NAVs a year48176

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundBaroda BNP Paribas ESG Best-in-Class Strategy Fund
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR——

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth